1 Glorious Growth Stock Down 78% to Buy on the Dip in September

Docusign reported fiscal 2027 Q2 revenue of $875.7 million, above its $865 million-$869 million forecast and up 9% year over year, while GAAP net income rose 23% to $77.7 million as operating expenses increased only 2%. Its AI-powered Intelligent Agreement Management platform has reached roughly 40,000 of 1.9 million customers, with management forecasting IAM will account for about 18.5% of $3.55 billion in fiscal 2027 ARR, versus 2.3% at the end of fiscal 2025. The stock remains 78% below its 2021 peak but trades at a 4.1x sales multiple versus a historical 11.8x average, supporting the article's bullish long-term valuation case.

Analysis

DOCU’s investable question is whether IAM produces net-new wallet share rather than merely migrating existing eSignature customers into a broader bundle. The installed base creates a low-CAC cross-sell channel, but the relevant evidence will be IAM-driven net retention, attach rates among enterprise accounts, and incremental ACV—not customer-adoption counts. If IAM can lift enterprise ARPU while sales-and-marketing remains disciplined, DOCU can transition from a low-growth workflow SaaS multiple toward the higher end of mature vertical-AI peers; failure would leave it competing on price with Adobe Sign, Microsoft’s workflow stack, and private CLM vendors such as Ironclad.

Margin expansion is supportive near term but has a ceiling: reduced operating-expense growth can mask weakening demand, and stock compensation remains a meaningful economic cost that limits per-share FCF compounding. The more consequential second-order risk is that generative AI lowers the barrier to basic contract extraction and search, making repository scale less defensible unless DOCU demonstrates superior workflow automation, compliance controls, and integration depth. Over the next 1-3 months, earnings commentary on enterprise seat expansion and IAM renewal behavior matters more than another modest revenue beat; over 6-18 months, the key catalyst is proof that agent-based negotiation/drafting drives measurable customer ROI and durable pricing power.

Consensus appears too focused on the headline valuation discount versus DOCU’s own historical multiple. That historical range was earned during a very different growth and rate regime, so multiple re-rating requires sustained acceleration in subscription growth or materially stronger FCF per share—not simply AI product announcements. Conversely, the stock may be underappreciated as a cash-generative turnaround if management can keep dilution contained while converting even a modest portion of its installed base to higher-value agreement-management workflows.

Key Decisions for Investors

• Maintain a tactical long bias in DOCU only on confirmation: add after the next earnings release if IAM ARR mix rises sequentially and total subscription growth accelerates above the current run-rate without a material increase in sales-and-marketing expense. Target a 15-25% upside over 6-12 months from multiple re-rating; exit if management cuts ARR guidance or dollar-based net retention deteriorates.
• Use a defined-risk bullish structure rather than chasing AI rhetoric: buy 6-9 month DOCU call spreads, financed only partially with out-of-the-money puts if implied volatility is elevated. The thesis needs time for renewal and cross-sell data; maximum loss should be limited to premium because a weak enterprise renewal cycle can compress the multiple quickly.
• For relative-value exposure, consider long DOCU / short ADBE in equal beta-adjusted dollars over 3-6 months if IAM booking momentum is independently validated. DOCU has greater upside torque to successful CLM monetization, while ADBE has broader AI expectations embedded; close the pair if Adobe demonstrates accelerating Document Cloud growth or DOCU’s IAM penetration stalls.
• Set a dilution watch item: do not increase gross exposure if trailing-12-month share count rises faster than operating cash flow per share. A strong non-GAAP earnings print without per-share FCF growth would falsify the quality-of-earnings component of the bull case.